Page 1

ReWalk Robotics ReWalk Robotics Reports Third Quarter 2021 Financial Results November 10 , 2021 9:30 PM EST MARLBOROUGH , Mass . and BERLIN and YOKNEAM ILIT , Israel , Nov. 10 , 2021 ( GLOBE NEWSWIRE ) -- ReWalk Robotics Ltd. ( Nasdaq : RWLK ) ( " ReWalk " or the " Company " ) today announced its financial results for the three and nine months ended September 30 , 2021 . Highlights of and subsequent to the third quarter of 2021 include : • Total revenue of $ 2.0 million reported for the third quarter of 2021 • Gross margin of approximately 58 % in the third quarter of 2021 • Received FDA breakthrough device designation for ReBoot , a soft exoskeleton for stroke home and community use • Strengthened cash position of $ 91.2 million , including a $ 32.5 million registered direct offering closed in September " During the third quarter we have continued to demonstrate quarter over quarter growth and the results in Q3 2021 marks our highest quarterly revenue for the last 4 years . Growth came from personal ReWalk placements in Germany and with the placement of multiple systems at a U.S physical therapy university where Exoskeleton training is becoming a core part of the curriculum as this field moves towards being a standard of care , " said Larry Jasinski , ReWalk's Chief Executive Officer . " We continue to see the opening of our main markets and looking forward to continue our positive momentum as we close 2021. " Third Quarter 2021 Financial Results Total revenue was $ 2.0 million in the third quarter of 2021 , compared to $ 0.7 million during the third quarter of the prior year . The increase is mainly due to the higher number of ReWalk Personal 6.0 units sold in Germany as well as a multiple unit order to a U.S physical therapy university . Gross margin was 58 % during the third quarter of 2021 , compared to 52 % in the third quarter of 2020. The increase is mainly due to the higher number of units sold and increased average selling price . Total operating expenses in the third quarter of 2021 were $ 3.8 million , compared to $ 3.5 million in the third quarter of the prior year . The increase is due to higher SG & A employee and employee related expenses as well as increased professional services offset with reduced R & D employee and employee related expenses . Net loss was $ 2.7 million for the third quarter of 2021 , compared to a net loss of $ 3.3 million in the third quarter of the prior year . Non - GAAP net loss was $ 2.0 million in the third quarter of 2021 , compared to $ 3.0 million during the third quarter of the prior year . Reconciliation of net loss to non - GAAP net loss is included at the end of this press release . Liquidity As of September 30 , 2021 , ReWalk had $ 91.2 million in cash on its balance sheet . Conference Call ReWalk management will host its third quarter 2021 conference call as follows : Date Time Telephone Access code U.S : International : Israel : Germany : Thursday , November 11 , 2021 8:30 AM EST ( 844 ) 423-9889 ( 716 ) 247-5804 18 09 31 53 62 08 00 18 15 287 4692387 Webcast ( live , listen - only and archive ) www.rewalk.com_under the " Investors " section . The archived webcast will be available via the following URL https://edge.media-server.com/mmc/p/h495e8p4 or through the ' Investors ' section ' on www.rewalk.com . About ReWalk Robotics Ltd. ReWalk Robotics Ltd. develops , manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke . ReWalk's mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies . Founded in 2001 , ReWalk has headquarters in the U.S. , Israel and Germany . For more information on the ReWalk systems , please visit www.rewalk.com .